SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹627 Cr | ₹559 Cr | ₹537 Cr | ₹513 Cr | ₹515 Cr |
What is the latest Total Current Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹627 Cr |
Mar2023 | ₹559 Cr |
Mar2022 | ₹537 Cr |
Mar2021 | ₹513 Cr |
Mar2020 | ₹515 Cr |
How is Total Current Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹627 Cr | 12.21 | |
Mar2023 | ₹559 Cr | 3.98 | |
Mar2022 | ₹537 Cr | 4.72 | |
Mar2021 | ₹513 Cr | -0.34 | |
Mar2020 | ₹515 Cr | - |
Compare Total Current Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹3,420.3 Cr | -11.8% | -10.1% | 14.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,012.0 Cr | 4.6% | -0.9% | 5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,188.0 Cr | 0.5% | -5.5% | 57.2% | Stock Analytics | |
CIPLA | ₹118,041.0 Cr | 0.2% | 0.6% | -3.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,512.0 Cr | -0.4% | -1.5% | 14.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,445.1 Cr | -2.2% | -8.6% | -13.4% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | -11.8% |
-10.1% |
14.1% |
SENSEX | -0.7% |
-4.5% |
-0.4% |
You may also like the below Video Courses